Dover has entered right into a definitive agreement to amass Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will broaden Dover’s biopharma single-use production offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue through the full yr 2022.
When the deal closes, Malema will become a part of the PSG enterprise unit within Dover’s Pumps & Process Solutions section.
“We see an incredible long-term development opportunity within the bioprocessing industry driven by a powerful and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of extra environment friendly single-use production processes supports a sturdy outlook for our choices of single-use elements to end-customers. We consider that pairing Malema’s know-how with our present portfolio of single-use pumps for biopharma processing will significantly enhance the accuracy and value proposition of our solutions to our prospects.”
“We are methodically constructing out our biopharma platform by way of proactive capacity additions, new product growth, and opportunistic acquisitions of highly-attractive niche component technologies,” said Richard Tobin, president and CEO of Dover. “ diaphragm seal represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary expertise. In เกจวัดแรงดัน to attractive biopharma purposes, we anticipate strong development in the semiconductor area on the capacity growth and re-shoring tailwinds.”
Share